Norden Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$582K Sell
2,079
-417
-17% -$110K 0.05% 336
2026
Q1
$666K Sell
2,496
-200
-7% -$54.2K 0.06% 268
2025
Q4
$676K Sell
2,696
-14
-0.5% -$3.72K 0.07% 273
2025
Q3
$778K Sell
2,710
-785
-22% -$210K 0.08% 243
2025
Q2
$917K Buy
3,495
+33
+1% +$8.04K 0.1% 199
2025
Q1
$806K Buy
3,462
+308
+10% +$74.7K 0.09% 210
2024
Q4
$723K Buy
3,154
+548
+21% +$126K 0.08% 256
2024
Q3
$582K Buy
+2,606
New +$573K 0.07% 291

Other funds holding LH

Norden Group's LH Position: Q2 2026 in Review

Norden Group reduced its Labcorp (LH) stake by 17% in Q2 2026, selling an estimated $110K and leaving 2,079 shares worth $582K. The position accounts for 0.05% of the portfolio, ranked #336.

Norden Group first reported a position in LH in Q3 2024 and has held it in 8 quarters since. The position peaked at $917K in Q2 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Norden Group held 2,079 shares of Labcorp worth $582K as of Q2 2026.
  • Norden Group sold 417 Labcorp shares in Q2 2026, an estimated $110K.
  • Labcorp made up 0.05% of Norden Group's portfolio in Q2 2026, its #336 holding.
  • Norden Group first reported a position in Labcorp in Q3 2024 and has held it in 8 quarters since.
  • Norden Group's Labcorp position peaked at $917K in Q2 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.